Table 4.
Black | White | |||
---|---|---|---|---|
|
||||
Below median PEA* n=513 |
Above median PEA* n=526 |
N=4213 | p for interaction | |
EDVI, mL/m2 | 2.57 ± 0.46y | 0.47 ± 0.43 | −0.33 ± 0.17z | <0.001 |
LV mass/BSA, g/m2 | 5.47 ± 0.85y | 0.35 ± 0.87 | 0.16 ± 0.32 | <0.001 |
LV mass/height2.7, g/m2.7 | 2.81 ± 0.42y | 0.55 ± 0.44 | 0.36 ± 0.15z | < 0.001 |
LA volume index, mL/m2 | 0.83 ± 0.32z | −0.83 ± 0.37z | −0.92 ± 0.13y | <0.001 |
Ejection fraction, % | −2.14 ± 0.26y | −2.18 ± 0.29y | −1.38 ± 0.10y | 0.001 |
E/e′ ratio | 0.67 ± 0.17y | 0.22 ± 0.18 | −0.32 ± 0.06y | <0.001 |
BSA – body surface area, LA – left atrium, LV – left ventricle, EDVI – end-diastolic volume index, PEA – proportion of European Ancestry.
Values are the coefficient (β ± SE) for each 1 SD increase in arterial elastance adjusted by age, sex, body mass index, use of anti-hypertensive, diabetes mellitus, heart rate and prevalent coronary heart disease or heart failure.
PEA was 0.11 ± 0.03 and 0.25 ± 0.10 for blacks with below and above median PEA groups, respectively.
p < 0.001;
p < 0.05